Convergent development of unique treatment systems for retinal disorders
Convergent development of unique treatment systems for retinal disorders
Oxular’s technologies were developed together to find solutions that would solve significant remaining unmet challenges in retinal care. Together, these systems will transform the treatment of retinal disorders.
Oxulumis®
Oxulumis is a minimally invasive, semi-automated administration device for routine delivery of therapeutics via an illuminated microcatheter to the posterior suprachoroidal space of the eye
Key features
Tissue interface accommodates variations in scleral thickness
Semi-automated deployment of microcatheter reliably accesses the suprachoroidal space
Transscleral illumination of microcatheter confirms accurate deployment
Posterior placement of microcatheter adjacent to specific tissues involved in retinal disease
Key benefits
Minimally invasive in-office procedure with small-gauge needle insertion
Does not penetrate the intraocular space
Enables safe, routine drug administration
Drug delivery only occurs after visual confirmation of correct microcatheter placement (ensures accurate drug delivery)
Delivers drug products alongside the posterior retina and macula
